Rapid reviews may produce different results to systematic reviews:a meta-epidemiological study by Marshall, Iain J. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.jclinepi.2018.12.015
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Marshall, I. J., Marshall, R., Wallace, B. C., Brassey, J., & Thomas, J. (2019). Rapid reviews may produce
different results to systematic reviews: a meta-epidemiological study. Journal of Clinical Epidemiology, 109, 30-
41. https://doi.org/10.1016/j.jclinepi.2018.12.015
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 09. May. 2019
Journal of Clinical Epidemiology 109 (2019) 30e41ORIGINAL ARTICLE
Rapid reviews may produce different results to systematic reviews:
a meta-epidemiological study
Iain J. Marshalla,*, Rachel Marshallb, Byron C. Wallacec, Jon Brasseyd, James Thomase
aSchool of Population Health and Environmental Sciences, King’s College London, London, UK
bIndependent Researcher, London, UK
cCollege of Computer and Information Science, Northeastern University, Boston, MA, USA
dTRIP Database, Newport, UK
eUCL Institute of Education, University College London, London, UK
Accepted 19 December 2018; Published online 25 December 2018AbstractObjective: To simulate possible changes in systematic review results if rapid review methods were used.
Study Design and Setting: We recalculated meta-analyses for binary primary outcomes in Cochrane systematic reviews, simulating
rapid review methods. We simulated searching only PubMed, excluding older articles (5, 7, 10, 15, and 20 years before the search date),
excluding smaller trials (!50,!100, and!200 participants), and using the largest trial only. We examined percentage changes in pooled
odds ratios (ORs) (classed as no important change [!5%], small [!20%], moderate [!30%], or large [30%]), statistical significance,
and biases observed using rapid methods.
Results: Two thousand five hundred and twelve systematic reviews (16,088 studies) were included. Rapid methods resulted in the loss of all
data in 3.7e44.7% of meta-analyses. Searching only PubMed had the smallest risk of changed ORs (19% [477/2,512] were small changes or
greater; 10% [260/2,512] were moderate or greater). Changes in ORs varied substantially with each rapid review method; 8.4e21.3% were small,
1.9e8.8% were moderate, and 4.7e34.1% were large. Changes in statistical significance occurred in 6.5e38.6% of meta-analyses. Changes from
significant to nonsignificant were most common (2.1e13.7% meta-analyses). We found no evidence of bias with any rapid review method.
Conclusion: Searching PubMed only might be considered where a |10% risk of the primary outcome OR changing byO20% could be
tolerated. This could be the case in scoping reviews, resource limitation, or where syntheses are needed urgently. Other situations, such as
clinical guidelines and regulatory decisions, favor more comprehensive systematic review methods.  2018 The Authors. Published by
Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Key findings
 Our simulation using data from the Cochrane Library
found that rapid review methods may lead to different
results than conventional systematic reviews.
 The degree of change to the pooled odds ratio of
the meta-analysis varied substantially among the
rapid review methods we examined.
 Searching only PubMed had the smallest risk of
changed odds ratio. With this strategy 19% of
meta-analyses had small changes or greater; 10%
of meta-analyses had moderate changes or greater.
What this adds to what was known?
 Different methods for identifying studies in evi-
dence synthesis have been widely examined, but
mostly in the context of the effect on the number
of studies found.
 More recently, researchers have started to examine
whether missing studies has impact on the results
of a review.
 This analysis is the largest to date which examines
the effect of common rapid methods for study
identification on meta-analysis results.
What is the implication and what should change
now?
 PubMed-only searching might be considered in sit-
uations where a 10% risk of 20% change in odds
ratio for the primary outcome is tolerable.
 This might be the case for scoping reviews, where
there is resource limitation (financial or human), or
where a synthesis is needed urgently.
 For uses demanding high accuracy (e.g., national
guidelines and drug licensing decisions), a more
comprehensive systematic review likely remains
the best option.1 The magnitude of change which would lead an answer to be
‘‘wrong’’ was not precisely defined but left to the judgment of the
participants.1. Background
Systematic reviews are regarded as the gold standard
method for evidence synthesis but are time-consuming
and laborious to produce. Systematic reviews registered
with PROSPERO take, on average, 67 weeks from protocol
registration to publication [1].
This time frame can be too long, for example, in health
emergencies, where decisions may need to be taken in weeks,
days, or even hours, for example, during the 2014 Ebola
epidemic [2,3]. Systematic reviews are quickly outdated afterpublication [4] and resource limitation is an important reason
why they are not kept up-to-date [5]. ‘‘Rapid’’ syntheses take
methodological shortcuts and have become popular where
syntheses are needed to tight deadlines, or where a conven-
tional systematic review would be prohibitively expensive.
Rapid syntheses have quickly become a fundament of national
and international health policy, clinical guidelines, and health
technology appraisals [3,6e12].
A 2015 survey by Tricco et al. identified 50 unique rapid
methods, which had been used in evidence synthesis; these
often used less rigorous processes to identify studies to
include [13]. Common rapid methods include limiting
searches to a single database, limiting to English language,
and limiting by publication date, among many others. By
design these methods risk missing some studies but aim to
produce results similar enough to those from more exhaus-
tive systematic reviews to be useful. Wagner et al. conducted
an online questionnaire of 556 guideline developers and pol-
icy makers, aiming to find what risk of error would be
acceptable in rapid reviews [14]. They found that partici-
pants demanded very high levels of accuracy and would
tolerate a median risk of a wrong answer1 of 10% (interquar-
tile range [IQR] 5e15%). This was similar across public
health, pharmaceutical treatment, and prevention topics.
Complex search strategies (e.g., combining database
searching with hand-searching) retrieve more relevant
studies compared with single database searches [15]. How-
ever, Egger et al. found that using mainstream bibliographic
databases often produced similar statistical results in meta-
analysis, as compared with more extensive searching [16].
Similarly, Hartling et al. found that removing non-English
language studies and unpublished studies rarely affected
the results of systematic reviews in pediatrics [17].
Glasziou et al. in their evaluation of 200 meta-analyses
found that the results of the single ‘‘best’’ trial (defined as
the study with the most precise effect estimate) agreed with
the statistical significance of the associated meta-analysis in
81% of cases [18]. A reanalysis of 60 Cochrane systematic
reviews examining different combinations of rapid search
methods, found that conclusions were likely to change in
8e27% of cases, depending on the method, though the most
reliable ‘‘rapid’’ method was still reasonably comprehensive
(searches of MEDLINE, Embase, and CENTRAL plus
manual searching of reference lists) [19]. A 2018 review
compared 16 pairs of rapid and conventional systematic re-
views (on the same topics). They found that both approaches
yielded similar results for most reviews but identified two
cases where the rapid review had important differences in
conclusions [20]. To date, there has not been a large scale
evaluation of the effects of rapid review methods on the
numbers of lost studies and the resultant changes in meta-
analysis results. This simulation study addresses this gap.
Specifically, we evaluate the effects of strategies that can
Box 1 How work might be saved with the rapid
review methods
Limiting search to PubMed only
 Single search strategy to construct, and time saved
searching (and learning how to use) multiple
databases.
 No deduplication of citations from multiple data-
bases required.
 Reduced search retrieval, hence fewer abstracts to
screen.
 Fewer studies from which to extract data, quality
assess, and input into meta-analysis.
Limiting to a fixed search time period
 Reduced search retrieval, hence fewer abstracts to
screen.
 Fewer studies from which to extract data, quality
assess, and input into meta-analysis.
Setting a minimum number of participants
 Easy rule for excluding studies at abstract screen
stage (in principle abstracts could be excluded more
quickly after quickly scanning for sample size).
 Where participant numbers are not reported in the ab-
stract, the full text may still need to be scrutinized.
 Fewer papers to retrieve and studies from which to
extract data, quality assess, and input into meta-
analysis.
Limiting to the largest trial only
 Easily applicable rule for excluding studies, though
all abstracts would still need to be scrutinized (to
identify which trial is the largest).
 Fewer studies from which to extract data, quality
assess, and input into meta-analysis.
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and abstract screening stages). Enacting these strategies
might reduce workload at these early stages and also later
in the review process (see Box 1). Excluding studies early
in the process could reduce the need for full-text retrieval,
data extraction, and quality assessment; the latter tasks are
commonly done in duplicate.2 These XML files are the output of Cochrane’s RevMan software. Ex-
amples containing the systematic review statistical data may be down-
loaded from the webpage of any Cochrane review.
3 Statistical code is available at https://doi.org/10.5281/zenodo.
1447087.2. Methods
2.1. Overview
We conducted a meta-epidemiological study, simulating
the effect of rapid review methods on meta-analyses in the
Cochrane library. We reconducted all meta-analyses of bi-
nary primary outcomes, first including all studies (‘‘system-
atic’’ method), and then repeating the meta-analysis after
withholding studies we judged would be lost using a rapidreview method (the ‘‘rapid’’ method). An overview of our
approach is shown in Fig. 1. We focused on methods
amenable to large-scale simulation using these data.2.2. Eligibility criteria
We analyzed all systematic reviews from the Cochrane
Database of Systematic Reviews (CDSR) published as of
July 5th 2018 meeting the following criteria. Reviews were
included if they included at least one meta-analysis, and if
the primary outcome (numbered 1.1 in the reviews) was a
binary variable and used a relative effect measure (risk ratio
[RR] or odds ratio [OR]). All other systematic reviews were
excluded. We chose binary outcomes in order that we could
categorize changes in ORs.2.3. Data extraction
All data extraction was scripted in Python from semi-
structured systematic review data (in XML format) made
available to us for research purposes by the Cochrane
Collaboration.2 We extracted the following data items: cita-
tion information for included studies, risk of bias assess-
ments for included studies, primary outcome name and
type (binary/continuous), meta-analysis method, event rates
(number experiencing outcome and total number partici-
pants) from each arm of all included studies.
We conducted meta-analyses using the meta package in
R, using the same methods as used in the original review
(matching fixed/random effects models; Mantel-Haenszel/
Peto/inverse variance methods)3 and expressed all as ORs
[21]. At baseline, all original studies were included in the
meta-analysis. We then simulated the effect of each rapid
review method by withholding selected studies and redoing
the meta-analysis.
We simulated the following rapid methods: searching
PubMed only; limiting search by publication date (cutoffs
of 5, 7, 10, 15, and 20 years before search date); limiting
inclusion by sample size (minimum of 50, 100, and 200);
and using the largest trial only. We chose these methods
in particular, as they are commonly used in existing rapid
syntheses [13] or proposed and evaluated in the evidence
synthesis literature [18,22]. We focused on methods that
we could simulate algorithmically at scale. Other
commonly used rapid methods (such as having abstracts
screened by a single reviewer, limiting to English language
only) are frequently described in the rapid review literature
but were not amenable to a large-scale simulation. We
therefore have not studied these methods exhaustively.
We describe how these methods would potentially
reduce workload in Box 1.
Fig. 1. Overview of the study.
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We did not reproduce the reviews’ PubMed search strate-
gies, but instead assessed whether primary studies were in-
dexed in PubMed. This strategy assumes that all studies
indexed in PubMed would be findable.4 To determine which
studies were PubMed indexed, we used three matching strate-
gies. We first retrieved citation information for included
studies from each systematic review. Article citations in sys-
tematic reviews frequently have minor typographical differ-
ences from their associated PubMed record. Therefore, a
naive strategy of exactly matching article titles from the refer-
ence list to the PubMed entry would fail often. To overcome
this, we made multiple searches of a local copy of the
PubMed database for study citation fields from the original re-
view (title, authors, publication date, and journal title), using a
‘‘fuzzy’’ matching algorithm for text strings5. Articles with a
high degree of matching for all of these fields6 were deemed
matches. We also searched Mendeley (using their search
API7) and the Cochrane Register of Studies (using the unique4 PubMed-indexed studies might not be found if a rapid review used an
inadequate search query; this issue is considered further in the Discussion.
5 Fuzzy matching algorithms can detect closely matching but noniden-
tical text strings. In our case, this allowed matching references in Cochrane
reviews even if there were minor differences from the PubMed record
(because of, e.g., minor transcription errors or partial titles). We used
the Python package fuzzywuzzy (https://github.com/seatgeek/fuzzywuzzy).
6 We define as ‘‘high degree’’ of match as 100% matching titles be-
tween Cochrane and PubMed records, except where the journal title, pub-
lication year, or first author also exactly matched, in which case an
additional 3% discrepancy in titles was allowed, as measured by the fuzzy
matching algorithm.
7 Mendeley is a reference management system, which allows public
access to its extensive database of scholarly articles. We developed soft-
ware to query its database using its API (or Application Programming
Interface, https://dev.mendeley.com/), which allowed us to find PubMed
links for thousands of articles.Cochrane publication identifiers from the review) [23] to
retrieve additional links to PubMed records. A statistical
method known as capture-recapture is widely used in epide-
miology to estimate the completeness of population-based dis-
ease registers, where the true prevalence of a disease might
not be known [24]. We use the same method here to estimate
the completeness of our set of linked PubMed records. Using
this method, we estimate that 98.8% of linked PubMed re-
cords are retrieved by our multiple matching strategies. The
full details of this analysis are presented in Appendix 1.
Studies are frequently described in multiple journal arti-
cles. Where this occurred, we used the reference to a pri-
mary publication (as marked in the original systematic
review) and ignored any secondary publication records.
Typically, the primary publication is the main journal
article describing the key results of a trial, and secondary
publications might include protocols, conference abstracts,
or secondary analyses. In theory, considering the primary
publication only might overestimate the difference between
rapid and systematic syntheses. For example, consider aFig. 2. Flow diagram showing selection of meta-analyses for the
analysis.
Table 1. Effect of the rapid review methods on numbers of studies
found and included in meta-analyses
Strategy
Total studies found
(N [ 16,088)
Median studies
lost per
meta-analysis
(IQR) [baseline
4, IQR 2e7]
PubMed-only search
(primary reference
in PubMed)
14,255 (88.6%) 0 (0e1)
PubMed-only search
(any reference in
PubMed)a
14,540 (90.4%) 0 (0e1)
Search 5 yr 4,004 (24.9%) 2 (1e5)
Search 7 yr 5,437 (33.8%) 2 (1e5)
Search 10 yr 7,425 (46.2%) 2 (0e4)
Search 15 yr 10,225 (63.6%) 1 (0e2)
Search 20 yr 12,404 (77.1%) 0 (0e1)
Exclude !50 people 12,439 (77.3%) 1 (0e2)
Exclude !100 people 8,406 (52.3%) 2 (0e4)
Exclude !200 people 4,891 (30.4%) 2 (1e5)
Largest trial only 2,512 (15.6%) 3 (1e6)
a Sensitivity analysis.
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outcome reported in a secondary publication. In this case,
if the secondary publication happened to be indexed in
PubMed, but the primary publication was not, we would
have wrongly excluded the data in our analysis.
In practice, we assume this would happen rarely, partic-
ularly given that we are considering the primary outcomes
in the systematic review only, which would be expected to
be reported in the primary study publications.
To investigate what would happen if this assumption was
not true, we conducted a sensitivity analysis, where we
included studies if any of their publications were indexedTable 2. Changes in pooled effect estimates for rapid methods used (n 5 2
Strategy No important change Small
PubMed-only search (primary reference
in PubMed)
2,035 (81.0%) 212 (8.4%
PubMed-only search (any reference
in PubMed)a
2,113 (84.1%) 177 (7.0%
Search 5 yr 480 (19.1%) 307 (12.2
Search 7 yr 686 (27.3%) 323 (12.9
Search 10 yr 978 (38.9%) 337 (13.4
Search 15 yr 1,425 (56.7%) 304 (12.1
Search 20 yr 1,779 (70.8%) 217 (8.6%
Exclude !50 people 1,717 (68.4%) 307 (12.2
Exclude !100 people 1,152 (45.9%) 358 (14.3
Exclude !200 people 713 (28.4%) 323 (12.9
Largest trial only 853 (34.0%) 536 (21.3
a Sensitivity analysis.in PubMed. The sensitivity analysis would be expected to
underestimate degree of change in the rapid synthesis
(because it optimistically assumes that all data relevant to
the meta-analysis could be retrieved from the easiest-to-
find publication) but would provide a lower bound on the
likely effects of PubMed-only searching.
2.5. Limiting inclusion by publication date
To simulate time-limited searching, we retrieved the
search date from the original systematic review. We then
determined whether studies should be included based on
the publication date taken from citation information in
the systematic review.
2.6. Excluding smaller trials/largest trial-only
strategies
For sample size cutoffs and largest trial strategies, sam-
ple sizes were estimated as the number of people from each
study, who contributed data to the meta-analysis. This
would comprise people who completed the study and had
the outcome measured from the two arms forming the pair-
wise comparison of interest in the meta-analysis. This does
not necessarily equal the number of participants random-
ized (e.g., for trials with O2 arms, or where not all partic-
ipants randomized were included in the study analysis). For
the largest trial-only strategy, odds ratios were calculated
directly from the trial event rates.
2.7. Changes in pooled effect estimates
We initially defined effect size changes approximating
Cohen’s rule (where changes of 0.2 SDs are described as
small, changes of 0.5 SDs as moderate, and 0.8 SDs as
large). This system has been widely used for defining mini-
mal important differences and is supported by empirical,512 meta-analyses)
Moderate Large All events lost All studies lost
) 48 (1.9%) 119 (4.7%) 4 (0.2%) 94 (3.7%)
) 41 (1.6%) 94 (3.7%) 4 (0.2%) 83 (3.3%)
%) 98 (3.9%) 387 (15.4%) 30 (1.2%) 1,210 (48.2%)
%) 99 (3.9%) 394 (15.7%) 29 (1.2%) 981 (39.1%)
%) 97 (3.9%) 352 (14.0%) 15 (0.6%) 733 (29.2%)
%) 80 (3.2%) 244 (9.7%) 17 (0.7%) 442 (17.6%)
) 65 (2.6%) 179 (7.1%) 8 (0.3%) 264 (10.5%)
%) 76 (3.0%) 166 (6.6%) 5 (0.2%) 241 (9.6%)
%) 105 (4.2%) 265 (10.5%) 13 (0.5%) 619 (24.6%)
%) 87 (3.5%) 255 (10.2%) 10 (0.4%) 1,124 (44.7%)
%) 221 (8.8%) 856 (34.1%) 46 (1.8%) 0 (0%)
Fig. 3. Change in pooled effect estimates with each rapid method.
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points [25]. The SD of log ORs in our data set is 0.359,
and hence this would have corresponded to 7%, 20%, and
33% relative change in the raw OR.8 We made a pragmatic
decision to align our cutoffs with those used in other similar
studies as far as possible [17,26] and therefore rounded these
figures, defining changes of pooled ORs of !5% as unim-
portant, !20% as small, !30% as moderate, and 30%
as large. We defined ‘‘loss of all data’’ as cases in which
the rapid method either did not find any trials or found only
trials where the outcome does not occur in either arm
contributing to the meta-analysis.
2.8. Changes in statistical significance
Statistical significance was calculated using the 95%
confidence intervals of the meta-analysis result and were
classed as changes from statistically significant to nonsig-
nificant; from nonsignificant to significant; and a change
in effect direction (i.e., a change from significance positive
effect to negative effect or vice versa).
2.9. Bias due to rapid methods
Weassessedboth risksof bias (i.e.,whether problems in the
design and conduct of studies existed which risked biasing
their results) and measured any systematic bias directly in
the pooled effect estimates, comparing the results of the rapid
vs. systematic syntheses. To assess risks of bias, we used the
CochraneRiskofBias tool assessments of the original system-
atic review authors [27]. The types of bias assessed with this
tool vary somewhat among reviews, and the systematic re-
views did not use standardized text to describe the type of bias
(e.g., problems in randomization are described as ‘‘Randomi-
zation method’’, and ‘‘Adequate sequence generation?’’
among many others). We therefore manually mapped the
free-text descriptions to the domains of the Cochrane tool.
Because they were done most commonly, we evaluated risks
of bias because of problems in random sequence generation,
allocation concealment, blinding of participants and
personnel, and blinding of outcome assessment.
The Cochrane Risk of Bias tool recommends that blind-
ing should be assessed separately for each outcome in a
study (e.g., inadequate blinding of trial participants may8 N.B. that a fixed absolute change in the logarithm of an OR is asso-
ciated with a constant relative change in the raw OR.lead to a high risk of bias for subjective outcomes but is less
likely to affect objective outcomes such as mortality, which
could be rated as having a low risk of bias). Where a sys-
tematic review contained bias judgments for more than
one outcome, we (manually) selected the judgment associ-
ated with the primary outcome.
To analyze the size and direction of any systematic bias
because of the rapid methods, we used the subset of meta-
analyses which had an inactive control (i.e., placebo, no treat-
ment, or usual care arm; a complete definition is provided in
Appendix 2). We reoriented all meta-analyses so that ORs!
1 indicated a beneficial outcome with intervention. ORs O1
favored control. We calculated percentage changes in the
pooled OR between systematic and rapid methods. The size
and direction of systematic bias were assessed through visual
inspection of histograms and calculating the mean percentage
change inORwith95%confidence intervals for the results from
the rapidmethod vs. the results from the full systematic review.
3. Results
3.1. Data selection
In July 2018, 7,122 systematic reviews were available in to-
tal in the Cochrane Database of Systematic Reviews. From
these, we excluded 4,160 reviews as they lacked a suitable
meta-analysis (no meta-analysis for a primary outcome 5
2,470, continuous outcome assessed5 2,084, absolute risk dif-
ference calculated only 5 56; see Fig. 2 for the flow of data).
The meta-analyses of the primary outcomes of the re-
maining 2,512 systematic reviews (including a total of
16,088 studies) were included in the final analysis. A
description of the number of studies lost with each rapid
method is presented in Table 1. Meta-analyses included a
median of four studies (IQR 2e7).
3.2. Change in pooled effect estimates
Changes in the pooled effect estimates between the rapid
and systematic methods are presented in Table 2 and Fig. 3.
The proportion of meta-analyses with complete data loss
varied widely between methods, with the largest trial-only
strategy least likely to lose all data (!2% of cases)9 and
limiting search to 5 years leading to greatest data loss
(around half of cases).9 Noting that if the largest trial had no events in either arm, the
meta-analysis would have no useful data.
Table 3. Effect of rapid review methods on the statistical significance of results (n 5 2,512 meta-analyses)
Strategy
No change in
significance
Significant to
nonsignificant
Nonsignificant to
significant
Change in effect
direction
All events
lost All studies lost
PubMed-only search (primary
reference in PubMed)
2,348 (93.5%) 52 (2.1%) 14 (0.6%) 0 (0.0%) 4 (0.2%) 94 (3.7%)
PubMed-only search (any
reference in PubMed)a
2,376 (94.6%) 40 (1.6%) 9 (0.4%) 0 (0.0%) 4 (0.2%) 83 (3.3%)
Search 5 yr 1,040 (41.4%) 201 (8.0%) 29 (1.2%) 2 (0.1%) 30 (1.2%)1,210 (48.2%)
Search 7 yr 1,266 (50.4%) 197 (7.8%) 38 (1.5%) 1 (0.0%) 29 (1.2%) 981 (39.1%)
Search 10 yr 1,569 (62.5%) 160 (6.4%) 35 (1.4%) 0 (0.0%) 15 (0.6%) 733 (29.2%)
Search 15 yr 1,907 (75.9%) 123 (4.9%) 23 (0.9%) 0 (0.0%) 17 (0.7%) 442 (17.6%)
Search 20 yr 2,141 (85.2%) 78 (3.1%) 21 (0.8%) 0 (0.0%) 8 (0.3%) 264 (10.5%)
Exclude !50 people 2,180 (86.8%) 65 (2.6%) 21 (0.8%) 0 (0.0%) 5 (0.2%) 241 (9.6%)
Exclude !100 people 1,729 (68.8%) 117 (4.7%) 34 (1.4%) 0 (0.0%) 13 (0.5%) 619 (24.6%)
Exclude !200 people 1,222 (48.6%) 124 (4.9%) 32 (1.3%) 0 (0.0%) 10 (0.4%)1,124 (44.7%)
Largest trial only 2,045 (81.4%) 343 (13.7%) 76 (3.0%) 2 (0.1%) 46 (1.8%) 0 (0.0%)
a Sensitivity analysis.
36 I.J. Marshall et al. / Journal of Clinical Epidemiology 109 (2019) 30e41The strategy with the least impact on pooled effect es-
timates was simulated PubMed-only search (19% of re-
sults had 5% change), with the two next best
strategies (limiting search to 20 years and excluding tri-
als with !50 people), both leading to 5% change in
|30% of meta-analyses. Limiting search to 5 years had
greatest impact (82% of results with 5% change). A
majority of effect size changes were small (8.4e21.3%
of meta-analyses across the methods) but moderate
(1.9e8.8%), and large changes (4.7e34.1%) were rela-
tively common.
3.3. Change in statistical significance
Changes in statistical significance with the rapid
methods are presented in Table 3 and Fig. 4. The least im-
pactful strategy was simulated PubMed-only search, which
produced changes in statistical significance in 6.5% of
cases. Excluding studies with !200 people led to changes
in statistical significance in more than half of cases. With
all methods, most changes were from statistically signifi-
cant (in the systematic review) to nonsignificant with the
rapid method, consistent with a loss of statistical power
(2.1e13.7% of meta-analyses). ‘‘False positive’’ statisticalFig. 4. Change in statistical significsignificance (i.e., statistical significance in the rapid
method, where the systematic review was nonsignificant)
was relatively rare (0.6e3.0% of meta-analyses).
3.4. Bias with rapid methods
Differences in risks of bias are presented in Table 4.
Studies ‘‘found’’ by the rapid methods were significantly
more likely to have a low risk of bias than those ‘‘lost’’.
This applied to all rapid methods and for biases due to in-
adequacies in random sequence generation, allocation
concealment, and blinding of outcome assessment. Studies
missed by the rapid methods had an absolute risk increase
of 8e25% of being at high risk of bias for these domains.
The exception was in bias because of inadequate blinding
of participants and personnel, where there was no differ-
ence in bias for the time-limited search strategies.
The analysis of bias in the meta-analysis results is pre-
sented in Table 5, which shows the mean percentage
changes in ORs with rapid method compared with sys-
tematic methods. Here, the meta-analysis outcomes were
aligned so that a negative % change indicates that rapid
methods favored the intervention arm on average; a pos-
itive % change indicates that rapid review methodsance with each rapid method.
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no systematic favoring of intervention or control with the
rapid method. Table 5 shows that the mean percentage
differences were small (i.e., indicating little or no sys-
tematic bias on average) and varied across different
methods, from a 1.6% change (favoring intervention)
with simulated PubMed-only searching to a þ4.5%
change (favoring control) with limiting search to
15 years. Most mean differences were not statistically
significant, with the exception of 15-year search
(þ4.5%, 95% CI þ 1.2% to þ7.9%) and excluding sam-
ples of !200 people (þ4.4%, 95% CI þ 1.1% to
þ7.9%). Histograms showed that the changes in results
appeared to have symmetrical distributions; these are
presented in Appendix 2.3.5. Sensitivity analyses for PubMed-only searching
As previously described, the sensitivity analysis
assumed that studies were ‘‘found’’ if any related article
was present in PubMed (a somewhat optimistic assumption,
but one which provides a useful lower bound on the
PubMed search estimates). The sensitivity analysis found
similar but modestly smaller impact of PubMed-only
searching than our primary analysis for all outcomes. Over-
all, the sensitivity analysis found that PubMed-only search
led to 5% change in pooled effect estimates in 15.9% of
cases and changes of statistical significance in 5.4% of
cases. The full breakdown of results is presented in
Tables 1e3. This similarity suggests our results are not
likely to vary substantially even if data from secondary
publications contributed to meta-analyses.4. Discussion
Despite increasing reliance on rapid reviews to inform
health policy and clinical practice, comparatively less had
been known about the reliability of their results, and
whether they met the standards decision makers require
[14]. All the rapid methods assessed in our analysis led to
small or greater changes exceeding the 10% tolerated ‘‘er-
ror rate’’ described in the survey by Wagner et al. [14]. For
situations where a moderate change in odds ratio could be
tolerated, PubMed-only search came very near to that
acceptability threshold (10.6% risk of 20% change in re-
sults). Overall, the changes varied substantially in impor-
tance. Critically, not all changes we observe would be
misleading. For example, a rapid review that finds no
studies is not likely to lead to a false conclusion but could
trigger a more comprehensive search (where resources
allow). Similarly, a small change in effect size might often
not lead to substantial changes in overall conclusions.
We assessed the effects of rapid review methods on
meta-analyses results for a primary outcome only; we were
not able to investigate rates of incorrect answers (as review
conclusions do not typically depend on a single meta-analysis result but would be expected to depend on analysis
from expert authors taking account of multiple beneficial
and harmful outcomes and knowledge of the topic).
In practice, the decision concerning whether to use rapid re-
view methods is complex; many factors other than an accept-
able error rate are important. For example, where there are
insufficient financial, human, or time resources, a full system-
atic review might be impossible. Rapid reviews with a higher
risk of incorrect conclusion than those found acceptable by
the participants in Wagner et al’s. study might be preferable
to no information at all [14]. Importantly, their assessment of
acceptable error rates did not take into account the (substantial)
opportunity cost of conducting comprehensive systematic re-
view methods for selected topics, where reviews still do not
exist for many clinically important questions.
Conversely, in a context where guideline authors may
also have their processes subject to judicial review
[28,29] the results of an evidence synthesis not only need
to be correct but also need to be seen to be correct. Failing
to include potentially relevant research could undermine
public confidence in the reliability of the process, even
where the final result is not importantly affected.
We described in Box 1 the tasks avoided. However,
there is comparatively little evidence about how much
time and effort might be saved by rapid methods short-
cuts. A survey of librarians found that translating a search
strategy for additional databases took on average 5 hours,
but with large variation, the maximum was 75 hours [30].
Shemilt et al. evaluated the cost-effectiveness of different
abstract-screening workflows, including the use of two re-
viewers, one reviewer, and automation [31]. Such a
design could prove useful in evaluating the time implica-
tions of other rapid review methods. In our analysis, since
we did not directly reproduce the search (and hence have
no knowledge of the volume of excluded articles), we
could not infer time or labor saving from the methods
examined.
A critical and unanswered question is whether methods
shortcuts are directly responsible for faster turnaround, or
whether other factors are at play. Rapid reviews are often
commissioned, and therefore might be more likely to be un-
dertaken by well resourced, experienced, and dedicated
teams, with tightly tracked deadlines. In addition, rapid re-
views are likely to be more focused in scope, which itself fa-
cilitates rapid production. How scope and working practices
rather than methods affect the time taken to conduct a review
remains poorly understood. Time saved by methods short-
cuts also need to be examined in the context of the (typically
large) total time and effort for a review. From the perspective
of a single review, even if searching multiple databases took
a little more time, it might not add meaningfully to a total
period that could be as long as 2 years. However, where a
large number of reviews are being done (e.g., national guide-
line organizations, Cochrane, and dedicated evidence synthe-
sis groups), small performance improvements accrue and
could become meaningful at scale.
Table 4. Difference in risks of bias between studies ‘‘lost’’ and studies ‘‘found’’ by the rapid methods
Strategy
Random sequence generation (high or unclear risk of bias)
Allocation concealment
(high or unclear risk of bias)
Studies lost Studies found P Studies lost Studies found
Citation in PubMed 862/1,328 (65%) 5,453/11,178 (49%) !0.001 1,277/1,743 (73%) 7,665/13,665 (56%)
Search 5 yr 5,285/9,307 (57%) 1,030/3,199 (32%) !0.001 7,193/11,567 (62%) 1,749/3,841 (46%)
Search 7 yr 4,841/8,193 (59%) 1,474/4,313 (34%) !0.001 6,486/10,196 (64%) 2,456/5,212 (47%)
Search 10 yr 4,129/6,625 (62%) 2,186/5,881 (37%) !0.001 5,442/8,270 (66%) 3,500/7,138 (49%)
Search 15 yr 2,990/4,478 (67%) 3,325/8,028 (41%) !0.001 3,831/5,564 (69%) 5,111/9,844 (52%)
Search 20 yr 1,977/2,819 (70%) 4,338/9,687 (45%) !0.001 2,504/3,464 (72%) 6,438/11,944 (54%)
Exclude !50 people 1,760/2,738 (64%) 4,555/9,768 (47%) !0.001 2,467/3,523 (70%) 6,475/11,885 (54%)
Exclude !100 people 3,519/5,891 (60%) 2,796/6,615 (42%) !0.001 5,001/7,409 (67%) 3,941/7,999 (49%)
Exclude !200 people 4,844/8,676 (56%) 1,471/3,830 (38%) !0.001 6,937/10,785 (64%) 2,005/4,623 (43%)
Largest trial only 5,571/10,594 (53%) 744/1,912 (39%) !0.001 7,781/12,978 (60%) 1,161/2,430 (48%)
P values calculated via chi-squared test.
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each review. Although this approach was chosen to identify
the most important analyses, the balance of multiple out-
comes may alter a review’s conclusions. Similarly, for re-
views examining adverse effects, information from
smaller or more difficult-to-find studies might be important
[32]. In systematic reviews that examine whether two inter-
ventions are equivalent (or similarly whether a new inter-
vention is noninferior to an older one), the size of the
confidence interval is critical [33]. We did not examine
changes in confidence intervals in detail (other than as a bi-
nary ‘‘significant’’/‘‘nonsignificant’’), and meta-analysis
changes that we categorized as showing ‘‘no important dif-
ference’’ statistically could hide critical differences in this
scenario.4.1. Importance of results change
We assume that the methods used in the CDSR represent
a gold standard. In practice, many reviews using a ‘‘full’’
systematic method do not adequately search for unpub-
lished literature, and therefore themselves provide an
imperfect estimate of treatment effects [34e36]. The most
frequent error type in our analysis was loss of all data.
Nearly half of all studies were lost overall when samples
!100 were excluded. The meta-analyses in our source data
incorporated a median of four studies, with studies having a
median of 101 participants. Analyses with small numbers
of studies with modest sample sizes will be particularly sus-
ceptible to change if some studies are not found.
It is possible that excluding small trials might improve
the accuracy of the final result by reducing the possibility
of small trials bias [37]. Dechartres et al. in their analysis
of 93 meta-analyses found that studies with sample size
!50 led to an exaggerated treatment effect of almost
50%, compared with trials having 1,000 participants
[38]. Notably, only 18% of the meta-analyses analyzed herecontained a study with 1,000 participants. Small trials
have been found to be more heterogeneous [39] and suscep-
tible to publication bias [37] than large trials; relying on the
largest study alone might, in some cases, be more valid than
a conventional systematic review approach. We addition-
ally found that excluded studies were generally at higher
risk of bias. If a rapid reviews strategy omitted smaller tri-
als at higher risk of bias, changed conclusions might be
more ‘‘correct’’ than the original.
This is similar to the findings of Egger et al., who inves-
tigated the effects of difficult-to-find studies (being those
which are unpublished, non-English language, and not in-
dexed in MEDLINE) via a secondary analysis of published
meta-analyses [16]. They found that the difficult-to-find
studies were less likely to have adequate allocation
concealment or blinding and concluded that if resources
were limited, researcher time might be better spent con-
ducting a rigorous bias assessment of the articles produced
from a limited literature search, rather than engaging in a
comprehensive search. However, we did not find evidence
of a systematic bias; most results from the rapid method
were close to the full systematic review result, and devia-
tions were equally likely to favor controls as interventions.
We note that biases have been found to vary in their effect
between studies and between different meta-analyses [40].
Our analysis therefore does not exclude the possibility of
bias in some areas (e.g., a 0% mean change could mask a
bias in rapid methods in favor of the intervention for one
clinical specialty, where the bias operates in a different di-
rection in trials in another specialty).
The analysis by Glasziou et al. found the trial with the
most precise results (typically the largest study) agreed in
statistical significance with full meta-analyses in 81% of
cases [18]. This aligns (exactly) with the results presented
here, where in 81% of cases the largest trial had the same
statistical significance as the full meta-analysis. Our anal-
ysis adds that in 3% of cases, the largest trial was
Table 4. Continued
Blinding of participants and personnel
(high or unclear risk of bias)
Blinding of outcome assessment
(high or unclear risk of bias)
P Studies lost Studies found P Studies lost Studies found P
!0.001 511/708 (72%) 3,494/5,925 (59%) !0.001 558/781 (71%) 3,707/6,608 (56%) !0.001
!0.001 2,948/4,859 (61%) 1,057/1,774 (60%) 0.44 3,248/5,398 (60%) 1,017/1,991 (51%) !0.001
!0.001 2,585/4,273 (60%) 1,420/2,360 (60%) 0.81 2,875/4,726 (61%) 1,390/2,663 (52%) !0.001
!0.001 2,125/3,516 (60%) 1,880/3,117 (60%) 0.94 2,404/3,896 (62%) 1,861/3,493 (53%) !0.001
!0.001 1,443/2,431 (59%) 2,562/4,202 (61%) 0.2 1,694/2,700 (63%) 2,571/4,689 (55%) !0.001
!0.001 962/1,560 (62%) 3,043/5,073 (60%) 0.25 1,132/1,734 (65%) 3,133/5,655 (55%) !0.001
!0.001 967/1,488 (65%) 3,038/5,145 (59%) !0.001 1,105/1,695 (65%) 3,160/5,694 (55%) !0.001
!0.001 2,042/3,176 (64%) 1,963/3,457 (57%) !0.001 2,255/3,533 (64%) 2,010/3,856 (52%) !0.001
!0.001 2,966/4,667 (64%) 1,039/1,966 (53%) !0.001 3,238/5,183 (62%) 1,027/2,206 (47%) !0.001
!0.001 3,393/5,550 (61%) 612/1,083 (57%) 0.005 3,672/6,216 (59%) 593/1,173 (51%) !0.001
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potentially misleading result. In over a third of cases, we
found a large difference in effect size between the largest
trial and the full meta-analysis. Whether this strategy is
useful would depend on the degree of approximation which
would be acceptable for a particular use.4.2. Strengths and weaknesses
This study provides the largest evaluation to date of
common rapid review methods for study identification on
a large corpus of systematic reviews, covering a wide range
of clinical areas. We have been able to examine effects notTable 5. Analysis of direction of change of meta-analysis results
(excluding meta-analyses with no change); Negative % change is
in favor of intervention efficacy
Strategy
Number of
meta-analyses
% change (SD), 95%
CI of mean
PubMed-only search
(primary reference
in PubMed)
1,497 1.6 (35.3), 4.4 to þ1.3
PubMed-only search
(any reference
in PubMed)a
1,503 2.9 (29.4), 5.5 to 0.3
Search 5 yr 790 þ3.5 (65.2), 0.6 to þ7.8
Search 7 yr 924 þ3.3 (71.2), 1.0 to þ7.7
Search 10 yr 1,090 þ1.8 (67.0), 2.1 to þ5.8
Search 15 yr 1,262 þ4.5 (47.5), þ1.2 to þ7.9
Search 20 yr 1,381 þ2.5 (50.9), 1.3 to þ6.4
Exclude !50 people 1,393 þ1.9 (39.6), 0.8 to þ4.7
Exclude !100 people 1,165 þ2.5 (43.1), 0.1 to þ5.3
Exclude !200 people 876 þ4.4 (52.0), þ1.1 to þ7.9
Largest trial only 1,533 þ3.3 (76.3), þ0.0 to þ6.7
a Sensitivity analysis.only on the number of studies found but also on whether
these change the results of the associated meta-analyses.
Our simulation closely approximated the rapid review
methods as they would be used in practice but did have
some areas of difference. We assumed the study population
size was equal to the number of people who contributed to
the meta-analysis (because these data were readily avail-
able). However, this number may not exactly match the
number of people enrolled (typically reported in study ab-
stracts), particularly if the study has additional arms that
do not contribute data, or if there is a high dropout/with-
drawal rate for the particular outcome assessed. Our strat-
egy could be reproduced from the title and abstract by
using the number of people in the arms of interest, rather
than the total. Likewise, if our strategy for retrieving
PubMed identifiers from included studies had imperfect
recall, it would underestimate the study retrieval for search-
ing PubMed only. We maximized recall by using three
separate matching processes, estimated to achieve O98%
recall via a capture-recapture analysis. Our simulation does
assume that all studies with a PubMed record would have
been identified by a PubMed search. It is possible that an
imperfect search strategy in the original review missed a
relevant study from PubMed, but that the study was identi-
fied by another means (e.g., search of additional databases,
or hand searching). Our simulation would underestimate
the impact of PubMed-only searching if this occurred.
Indeed, a 2016 reanalysis of searches from 120 systematic
reviews found that the coverage (being the percentage of
relevant articles actually in the database) of MEDLINE
(the major component of PubMed) was 92.3%. However,
recall (being the percentage of relevant articles actually
found using the systematic review’s documented search
strategy) was much lower at 72.6%.
We defined a single set of effect size cutoffs to charac-
terize changes across many meta-analyses. Importantly,
these describe the magnitude of change in statistical effect
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lation [25]. A very small change in effect size (below our
selected threshold) might be important, for example, where
the absolute risk of outcome is high (and hence a small
relative difference with an intervention has greater impact)
or with outcomes that are highly important to avoid (e.g.,
mortality). Synthesis producers should take these features
into account when deciding on whether a rapid review
shortcut might be justified.
Finally, we have examined the effects of a small selection
of rapid review methods only and focused on the identifica-
tion of studies. The effects of rapid review methods targeting
other review processes (e.g., having a single reviewer screen
abstracts or extract data, compared with the duplication of
processes as done in conventional systematic reviews) are
worthy of research. Likewise, the meta-analyses included
in our study differed in their characteristics (in terms of clin-
ical question, overall sample sizes, precision of pooled esti-
mates, and risks of bias), and we did not examine analyses
with continuous outcomes. Future research could investigate
whether meta-analyses with certain characteristics are less
liable to change when using rapid review methods compared
with others.
5. Conclusions
Different rapid synthesis methods vary greatly in their
impact, and the importance of changes to results is likely
to vary substantially for difference use cases and topics.
For researchers, the best performing strategy tested here
(PubMed-only searching) might be considered in situations
where odds ratio changes smaller than our moderate cutoff
for the primary outcome could be tolerated (this strategy
had a |10% risk of the OR changing byO20%). This might
be the case for scoping reviews, where there is resource lim-
itation (financial or human), or where a synthesis is needed
urgently. For uses demanding high accuracy (e.g., national
guidelines and drug licensing decisions), a more comprehen-
sive approach likely remains the best option.Acknowledgments
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